AKT1 and hepatocellular carcinoma: Bufalin, the potent antitumor compound isolated from medicine herbs, has been reported to boost anti-angiogenic effect of sorafenib via suppression of AKT/vascular endothelial growth factor (VEGF) signaling in HCC [36].